LITTLE FALLS, NJ--(Marketwire - June 08, 2011) - Regenicin, Inc.
) announces it is in advanced discussions with various developers in the State of Florida to determine the best strategic location and partners for the company to establish its research facilities. Sites presently being considered are world-class research and technology parks, which will allow Regenicin to collaborate with leading centers of excellence in the academic, research, and healthcare arenas.
The company is pursuing opportunities to lease new facilities that will not only accommodate the company's present needs for state-of-the-art lab space, but will also address the projected growth needs the company envisions as it executes its business plan.
The State of Florida is an exciting new destination for Regenicin and it offers many appealing amenities with logistical and financial considerations for the biotech and life sciences industries. We hope to be able to announce our site selection in the near future.
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including, without limitation, the future press releases of Regenicin, Inc.